Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders BioLineRx Ltd. Nasdaq

Equities

BLRX

US09071M2052

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.6988 USD -4.80% Intraday chart for BioLineRx Ltd. -2.81% -55.49%
May. 30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
May. 28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioLineRx Ltd. Appoints Gal Cohen to Its Board as a Class I Director
CI
BioLineRx Ltd. Approves Appointment of Kesselman & Kesselman as Independent Registered Public Accounting Firm for the Year Ending December 31, 2023
CI
BioLine Rx Ltd. Announces Executive Changes
CI
BioLineRx, Ltd. Announces the Departure of Arnon Aharon as Chief Medical Officer, Effective November 30, 2016
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. BLRX Stock
  5. News BioLineRx Ltd.
  6. Insiders